Skip to main content Skip to main content

Hives That Won’t Go Away? The New Treatments a Dermatologist Wants You to Know About

What to know about chronic spontaneous urticaria, plus the injectable and oral options for when antihistamines aren’t enough.

Image / Getty

When are hives considered chronic? When they last six weeks or more. If there’s no clear trigger, they may be diagnosed as chronic spontaneous urticaria (CSU), a condition that can bring relentless itching and swelling of the lips, face and body. Antihistamines are the go-to first treatment, but for many people with CSU, they aren’t enough.

“Chronic hives can be so itchy. They can be so detrimental to the quality of life,” says New Haven, CT dermatologist Christopher Bunick, MD.

When Are Hives Considered Chronic?

“We generally describe hives, also known as urticaria, as acute or chronic,” explains Dr. Bunick. “And the cutoff point between acute and chronic is considered six weeks.”

For some people, hives disappear within days. For others, the itchy welts repeatedly return, sometimes without any obvious reason. “If we don’t know the underlying cause, that’s when we call it chronic spontaneous urticaria,” he says. “You may hear it called CSU.”

And while it’s tempting to wait for the next flare-up to pass, Dr. Bunick encourages patients to seek help. “You should definitely see your dermatologist or allergist to get treatment, especially if it’s been going on six weeks or more.”

What Happens When Antihistamines Aren’t Enough?

Antihistamines are usually the first treatment recommended for hives, but they don’t work for everyone. “When we think about treating the hives, we’re commonly told that antihistamines are the way to treat it. And for many patients, that is okay,” says Dr. Bunick.

But for patients experiencing persistent outbreaks, the constant cycle of itching, swelling and temporary relief can become frustrating. Fortunately, treatment options have expanded significantly.

“We now have three major targeted therapies that can treat chronic hives at a really, really good high level,” he says.

New Treatments for Chronic Hives

The three targeted therapies Dr. Bunick highlights include Xolair (omalizumab), Dupixent (dupilumab) and Rhapsido (remibrutinib).

“The first that’s been around the longest is omalizumab,” he explains. “But the two new ones you may not have heard about are dupilumab and remibrutinib.”

Both Xolair and Dupixent are injectable medications, while Rhapsido is a twice-daily pill approved for adults with CSU. All three are intended for patients whose symptoms persist despite antihistamine treatment.

“The good news about these therapies, they have relatively quick onset of action,” says Dr. Bunick. “These are medicines that can be prescribed right in your dermatology office.”

For people who have spent months struggling to manage their symptoms, having more options can make a meaningful difference. “The possibilities have gone through the roof for treating patients with chronic hives,” he says.

If you’re still dealing with recurring hives despite taking antihistamines, a dermatologist or allergist can help determine whether one of these FDA-approved treatment options may be appropriate.

For more expert advice from board-certified doctors, visit the NewBeauty Rx portal.

FIND A DOCTOR

Find a NewBeauty "Top Beauty Doctor" Near you

Filter doctors by location and specialty
NewBeauty Magazine Cover
NEWBEAUTY

Give the Gift of Luxury

GIVE A SUBSCRIPTION